Podcasts about healthtech

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

How to Build a Marketing Team That People Don't Want to Leave On this episode host Adam Turinas sits down with Larry Kaiser, Chief Marketing Officer at Optimum Healthcare IT, for a candid conversation about what it really takes to build a marketing team that lasts. Larry has spent nearly a decade growing the marketing function at Optimum from a logo and an outdated Drupal website into a tight, high-performing team. The lessons he has picked up along the way are ones that any marketing leader in healthtech will recognize. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Karthik Ganesh, CEO of OnMed.OnMed is the healthcare technology company behind OnMed CareStation, a “Clinic-in-a-Box” designed to expand access to primary and urgent care. Before OnMed, Karthik served as CEO of EmpiRx Health, leading the company through rapid growth and a successful private equity transaction in 2021. Throughout his career, he's held leadership roles at QualCare, CareAllies, and Aetna, and advised healthcare organizations through Deloitte and EY.In this interview, Karthik discusses why hybrid care models still require a human touch, how enterprise healthcare buyers evaluate value propositions differently, why brand and culture should shape execution early, and how operating under constraints can sharpen innovation.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Karthik Ganesh, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - Karthik's obsession with healthcare access, and the “broken doorway” problem behind OnMed (05:51) - How OnMed combines telemedicine and brick-and-mortar care into a “Clinic in a Box” (09:04) - The OnMed metrics that surprised Karthik most, including a 37% patient return rate, and the reasons behind the company's success (09:22) - What OnMed designed differently after realizing that patients approach healthcare with their guard up (15:27) - The pitfalls of B2C healthcare and how OnMed was built as a B2B company by intention (22:01) - How Karthik reshaped OnMed around clarity, structure, and high performers (30:23) - What “brand” actually means to Karthik (39:37) - How OnMed tailored its value proposition for payers, providers, employers, and universities (45:45) - Karthik's fundraising philosophy: constraints keep companies inventive

Behavioral Health is Under Pressure, and Healthtech is Here to Help On this episode of In Practice, Dr. Robert Murry, chief medical officer at NextGen Healthcare, is joined by Javier Favela, vice president of market and segment strategy at NextGen Healthcare, and Erin Paige, solutions engineer at NextGen Healthcare and a licensed associate counselor, for a timely conversation on the pressures facing behavioral health organizations today. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman, founder and CEO of Clairity.Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram.A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imaging Specialist at Massachusetts General Brigham (on leave). She holds an MD and PhD from Yale and was named to Forbes' 50 Over 50 Innovators and TIME 100 World's Most Influential Leaders in Health.In this interview, Connie discusses her experience translating academic research into a commercially viable startup, the massive undertaking of generating clinical evidence when you're creating a new category, and how Clairity is approaching adoption on two fronts: fitting into physician workflows and building access pathways for patients.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Connie Lehman, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - The broken screening paradigm Connie saw in clinic — and the gap that became Clairity (05:09) - How Clairity rolls the clock back from detection to predicting risk in healthy women (07:31) - Why "more data is better" turned out to be wrong and how that shaped Clairity's product scope (21:57) - How physicians can translate grant-generating discipline into building a company (24:56) - What 18 months of pre-sub meetings revealed about navigating a de novo pathway (26:49) - Why Clairity validated its technology in over 250,000 mammograms when FDA required far less (34:43) - How Connie flipped the natural question from "how can doctors offer this?" to "how can women access it?" (43:47) - How relationships, not pitches, drove Clairity's $43M Series B

How much business are you losing simply because you're not staying in consistent contact with your audience? Most companies don't have a sales problem—they have a follow-up problem. And follow-up isn't about chasing people…it's about staying top of mind with value, relevance, and consistency. That's why my interview with Smita Wadhawan, CMO of Constant Contact, on the THINK Business – What Are You Good At? series hit on a hard truth—consistency is the new marketing advantage. Here are 5 takeaways that stood out: ✅ Mindshare → Market Share People can't buy from you if they forget you exist. Marketing isn't optional—it's oxygen. ✅ Consistency builds trust Trust isn't built in a moment—it's built in the follow-up moments people rarely do. ✅ Simple wins Customers don't want clever. They want clear. They want fast. They want relevant. ✅ Start now—then scale Stop overthinking platforms, funnels, or brand perfection. Start small. Ship. Learn. Improve. ✅ AI is here to help, not replace Use AI to automate repetitive work—so you can stay human where it matters most.   Smita Wadhawan Verma Global Chief Marketing Officer | Top 50 CMO | PayPal | Intuit | GoDaddy | Visa | SaaS | HealthTech | FinTech Award-winning Chief Marketing Officer with experience at GoDaddy, PayPal, Intuit, VISA, and SimplePractice — across SMB/consumer, SaaS, HealthTech, and FinTech. Global teams and global leadership at EcoVadis. Scaled and led businesses from a mid-size company to a $32B established brand, with budgets up to $175M. Expertise in growth marketing, product marketing, B2B and B2C marketing, lifecycle marketing, PR and comms. Smita has built and led teams of 150+ people in highly matrixed, cross-functional organizations across the US, Europe, Africa, Japan and India. She has partnered with top agencies like Koto, Instrument, Razorfish, TBWA, Highwire PR — and managed award-winning internal creative teams. Under Smita's leadership, her teams have won Digiday Awards and several Webby Award nominations. Smita is well known as a culture champion and recognized as a highly influential and inclusive C-Suite leader who can inspire teams to deliver outstanding results. Recognized as a 2024 Top 50 CMO in the US. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience Website: https://jondwoskin.comLinkedIn: https://www.linkedin.com/in/jondwoskin Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Jeff Gunsberg:Website: https://title-connect.com Connect with Smita Wadhawan:LinkedIn: https://www.linkedin.com/in/smitawadhawan/ *E - explicit language may be used in this podcast.

Most careers don't follow a straight line. But few require starting over in full view of the public.This week, Halle sits down with Lance Armstrong to discuss how he rebuilt his life and career after multiple turning points, including surviving advanced cancer, and how those experiences shaped his perspective on health, performance, and reinvention. Now, through his venture firm Next Ventures, he backs companies focused on what they call “whole person health” — spanning prevention, wellness, diagnostics, longevity, and healthcare outside the traditional system.We cover:Why he chose to become a VC, and what he likes (and dislikes) about the jobHow his experience as a patient shapes how he evaluates companiesWhy preventive care is growing outside the traditional healthcare systemWhat he looks for in founders building across the care continuumWhat it takes to rebuild trust and start overAbout our guest:Lance Armstrong is a former professional cyclist, entrepreneur, and investor. After surviving advanced testicular cancer, he founded Livestrong, helping raise more than $500 million to support cancer patients and survivors worldwide. In 2019, he co-founded Next Ventures, a venture capital firm focused on health, wellness, and consumer brands, with investments including Oura, Cofertility, Pair Team, and SteadyMD. Prior to Next Ventures, he was an active angel investor in companies such as Uber, DocuSign, and Athletic Brewing.—

A Practical Guide to Intent-Driven ABM and AI in Healthtech This episode is the final installment in a three-part miniseries on ABM and go-to-market strategy, and it is extremely practical. Host Adam Turinas is joined by guest Rehan Mirza, Chief Growth Officer at Verifiable, a credentialing automation platform that has lived through every stage of the ABM journey, from cold outbound blasting to sophisticated, intent-driven orchestration across a complex enterprise sales motion. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Ireland's growing reputation as a global leader in digital healthtech innovation was highlighted at a major industry event which took place at Trinity Business School. Scaling Digital Healthtech in Ireland, hosted by the four Irish European Digital Innovation Hubs (EDIH),in collaboration with Enterprise Europe Network and Ibec, saw over 400 stakeholders from across the health and life sciences sector come together to hear from leading experts across government, industry and academia, alongside panel discussions and case studies showcasing real-world innovation and impact. Digital Healthtech represents the combination of smart connected devices and AI-powered digital health tools which are transforming the delivery of healthcare and creating opportunities for new disruptive products and services by Irish companies. The event marks the first in a series of national engagements designed to support Irish SMEs and public sector organisations in accelerating the development and adoption of digitisation and to increase the awareness of supports which are already available. Ireland has established itself as a hub for cutting-edge healthtech innovation, supported by a thriving ecosystem of technology companies, researchers and policymakers. The event explored both the opportunities and challenges associated with scaling digital healthtech solutions, including artificial intelligence integration, regulatory compliance, cyber resilience, and access to funding and European markets. Speaking at the event, Minister of State for Trade Promotion, Artificial Intelligence and Digital Transformation Niamh Smyth TD underlined the Government's commitment to advancing Ireland's digital health ecosystem. "Today highlights the strength of Ireland's digital transformation and its growing, innovative healthtech ecosystem. The Government recognises the importance of maintaining and building on this momentum. At the end of 2025, €23 million was announced through my Department and the Digital Europe Programme to extend the European Digital Innovation Hubs (EDIH) Programme to 2029. This investment will enable our hubs to significantly accelerate digitalisation among SMEs and public sector organisations, delivering over 3,000 engagements, 1,100 "Test Before Invest" projects, and more than 200 training courses nationwide. "As work progresses on the National Life Sciences Strategy, Ireland is well positioned to lead the future development of this sector. Bringing together industry, innovation, and expertise is essential to achieving our shared ambition: supporting Irish companies to scale globally while delivering meaningful benefits for patients and healthcare systems. "These efforts are reinforced by a wide range of supports designed to help SMEs grow and internationalise their digital health solutions. These include Enterprise Ireland, the National Enterprise Hub, Local Enterprise Offices, Ibec, Health Innovation Hub Ireland, the European Enterprise Network, and the network of European Digital Innovation Hubs operating across Ireland." Joe Healy, Head of Research and Innovation at Enterprise Ireland said: "Through the European Digital Innovation Hubs, we are supporting Irish enterprises of all sizes and stages to harness advanced technologies, build capability, and compete internationally. This event demonstrates the importance of connecting the network to drive uptake of the supports on offer and strengthening collaboration across industry, government and academia." Ciara Finlay, Ibec Senior Executive said, "Demographic shifts accompanied by the rise of chronic diseases, coupled with the recent impact of the greatest global health emergency in over a century have highlighted the importance of fostering better health system resilience across the world. Digital Health is a solution that can unlock some of the challenges ahead. The digital health segment is estimated to grow at over 17.4% between 2021 and 2027 to €426 billion. "The Medtech, digital health...

Episode 77 - Sam Fay, CEO of SISU Health, is leading the mission to make preventative health more accessible. With 25 years' leadership experience, she has a proven track record in scaling organisations and driving measurable impact.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Ron Books on Human-First AI & Arizona Becoming a Health Tech Hub Ron Books, CEO of Net Health, talks about how he believes that AI is the only thing that can save the human element in healthcare, examples from the wound care and rehab therapy spaces, and how Arizona is becoming a health tech hub.  All that, plus the Flava of the Week about the CMS Health Tech Ecosystem's First Wave event. How significant was it to see demos from more than 50 companies that are making good on their pledge to create a fully digital, patient-centered health system, and what's your part in helping consumers understand and trust what's possible now? Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI in healthcare may be entering a new chapter, one where the biggest question is no longer whether the technology works, but who is willing to deploy it, measure it, and take responsibility for the risk.This week, Steve sits down again with Eric Larsen to revisit his predictions from last year's Webby-winning episode on generative AI in healthcare. Eric argues that the first wave of AI has been inflationary, reinforcing the old payer-provider payment model, but that the next wave could be deflationary as automation moves into revenue cycle, administrative work, clinical reasoning, and drug development. They discuss why incumbents still have a narrow window to co-develop the future, why clinical AI may move faster outside the US, and why liability may become the deciding factor in who wins.We cover:Why healthcare is still the sector most exposed to AI-driven changeHow AI has reinforced fee-for-service dynamics so far, and why that may soon reverseWhat makes some healthcare work more automatable than othersWhy liability may determine how fast clinical AI gets adoptedWhich health systems, payers, and life sciences companies are moving fastestWhat will change across providers, payers, and pharma over the next year—

What does the senior CMS official focused on payment and delivery innovation actually want health tech founders to understand? In this episode, we listen in on highlights from a recent fireside chat as StartUp Health co-founder Unity Stoakes talks with...

In this episode of Medsider Radio, we sat down with Antony Odell, co-founder and CEO of Echopoint Medical.Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics.Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tissue Regenix. He holds a BSc in Physiology and Biochemistry.In this interview, Antony discusses translating academic IP into a commercial device, choosing early clinical sites to balance speed and learning, managing non-dilutive funding as a long-term discipline, and outlines the most important responsibilities of an early-stage medtech CEO.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Antony Odell, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:06) - How Antony's career centered on translating clinical insights into commercial reality (05:54) - What Echopoint's iKOr does, and why 40% of cath lab patients leave without a diagnosis (12:13) - How Echopoint landed its first U.S. clinical site, and what that means for the company (13:48) - What to assess before spinning out an academic idea, and why clinician input is the first real test (20:14) - Why Echopoint chose Barts over typical sites for its first-in-human study (22:58) - How getting too close to one clinical site can lead to dangerous groupthink (30:54) - Why non-dilutive funding belongs on the board agenda permanently (39:54) - How CEOs should manage boards, control information flow, and avoid becoming a “glorified note-taker”

This episode is the final installment in a three-part miniseries on ABM and go-to-market strategy, and it is extremely practical. My guest is Rehan Mirza, Chief Growth Officer at Verifiable, a credentialing automation platform that has lived through every stage of the ABM journey, from cold outbound blasting to sophisticated, intent-driven orchestration across a complex enterprise sales motion.Rehan tells the story of how Verifiable evolved its ICP from fast-moving digital health startups to regional health plans with hundreds of thousands of providers, and why that shift forced a complete rethink of how marketing, BDR, and alliances teams operate together. He talks candidly about the early lesson that volume-based outbound erodes trust, especially in healthcare, and how that shaped a completely different philosophy built around delivering value before making an ask.If you are a healthcare technology marketer working through how to make ABM actually function inside your organization, this episode gives you a clear, honest view of what it takes. Rehan has the scars to prove it.Key Topics: "(00:00:00)" Introduction and the Sway Health Podcast of the Year Award"(00:03:00)" Bridging the gap between AI activity and revenue results"(00:05:00)" Defining credentialing and Verifiable's origin story"(00:07:00)" Transitioning from a free proof of concept to a Salesforce-integrated platform"(00:09:00)" Shifting from cold outbound to intent-based lead orchestration"(00:10:00)" Ideal Customer Profile (ICP) evolution: From digital health to major payers"(00:14:00)" Moving up-market and the role of hyper-focus in ABM"(00:15:00)" Rethinking attribution: Why 70 to 80 percent overlap is the goal"(00:18:00)" Moving from pipeline generation to pipeline acceleration"(00:22:00)" The CORE framework: Conversion, Orchestration, Resonance, and Ecosystems"(00:23:00)" Using AI SDRs as a channel rather than a replacement for humans"(00:25:00)" Lessons learned: Why volume-based "spamming" erodes trust in healthcare"(00:28:00)" Closing summary and key takeaways for ABM successIf you are interested in discussing this or any other topic, let's have a chat.  Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.Follow me on LinkedIn.Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.

Betsy Kauffman is a globally recognized executive leadership coach and organizational agility consultant with over 25 years of experience transforming Fortune 500 leadership teams into high-performing, aligned powerhouses. As Founder and CEO of Cross Impact Coaching, she partners with CEOs and their executive teams—primarily in HealthTech and FinTech—to align strategy, execution, and team dynamics for lasting results. Her signature Leadership Alignment Lab blends executive coaching, proprietary 360 feedback, and strategic offsites to help C-suites turn vision into action. She also co-owns Kauffman & Co. Furniture, giving her a unique perspective on scaling and leading both service- and product-based businesses.      

How to Connect Marketing to Revenue On this episode host Adam Turinas is joined by two guests who have done the real work of building a model that clearly connects marketing to revenue. First, Paula Cobb, VP of Marketing at AvaSure, a private equity-backed virtual care platform. Paula brings over 30 years of healthcare marketing experience and runs what she calls a peanut butter and jelly go-to-market model, where sales, marketing, and customer success are genuinely inseparable. What he find compelling about her perspective is how tightly she has wired marketing into product decisions and the fact that AI tools have essentially become named members of her org chart. His second guest is Alex Esquivel, VP of Marketing at Luma Health. Alex has an unusual background for a marketer. She came up through finance and operations, which gives her an unusually clear-eyed view of why the traditional MQL model was, in her words, doomed from the start. She describes what a genuinely revenue-accountable marketing model looks like in practice, including how she structures account-based motions, why she does not measure MQLs at all, and how she is moving from slow campaign cycles to fast, iterative content that responds to what buyers actually care about. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Ooni, one of the biggest names in pizza ovens, has new models for inside and outside your home (perfect for summer), and a new rotating stone accessory. We kick off the show with Ooni founder & co-CEO Kristian TapaninahoAlso, thrilled to have on the show for the first time, Dr. Bea Bakshi, co-founder and CEO of ‘C the Signs,' which helps identify a risk of cancer in patients at the earliest stage – and now in the U.S.Speaking of health, Garmin may be best known for its high-performance GPS smartwatches, but the company also has a portable blood pressure monitor called the Index BPM. Joining us on Tech It Out is Jill Hager, Project Manager at Garmin

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. At the recent ITAC Conference in Brisbane, one keynote stopped the room.While most AI presentations focus on efficiency, automation and productivity, Scottish Care CEO Dr Donald Macaskill delivered something very different: a deeply human conversation about dignity, autonomy, storytelling, privacy and what healthcare risks losing in the race toward artificial intelligence.In this episode of Pulse, Louise and George sit down with Donald to unpack Scotland's ethical and human rights-based approach to AI in aged care — and why he believes AI is not inevitable, but a choice.The conversation explores:the shift from person-centred to person-led care, why current AI systems often fail to reflect the lived experience of ageing, the risks of surveillance and opaque decision-making in care environments, how Scotland is using co-design and human rights frameworks to shape AI adoption, and why technology should enhance — never replace — human presence and relationships. Donald also shares practical lessons from Scottish initiatives including the Oxford Institute for Ethics in AI and the Coorie Well project, where residents, families and frontline staff helped shape AI tools from the ground up.And in a memorable closing exchange, Donald reflects on the one thing machines may never truly understand about care: laughter.A thoughtful, philosophical and surprisingly funny conversation about what it means to “hold fast” to humanity in the age of AI.Connect with Donald on LinkedIn Stryker Vocera's Initial Delays Diagnosis Quiz LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this episode of Medsider Radio, we sat down with Kurt Jacobus, co-founder and CEO of restor3d.restor3d provides patient-specific orthopedic implants using 3D printing and advanced software.Kurt has over two decades of experience in medtech entrepreneurship, including successful exits to Enovis and NuVasive. Prior to his career in medical devices, Kurt was a consultant at McKinsey & Company. He holds a PhD in Mechanical Engineering and is an Adjunct Professor at Georgia Tech. In this interview, Kurt discusses how restor3d used the FDA's 520(b) pathway to generate revenue and regulatory proof simultaneously, why self-regulating beyond FDA requirements makes submissions a competitive barrier, and how to approach investor relationships and board construction with long-term thinking.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kurt Jacobus.KEY MOMENTS FROM THE INTERVIEW(03:21) - How Kurt went from wanting to build race cars to 20 years of orthopedic entrepreneurship (06:03) - How restor3d's patient-specific implants challenge the “8 sizes fit 8 billion people” model (15:36) - Why early-stage companies should “ring the cash register” as soon as possible (17:16) - How a 520(b) pathway helped restor3d generate revenue before full FDA clearance (31:48) - How restor3d treats every FDA submission like a PhD thesis and holds itself to standards beyond what regulators ask for (35:24) - What Kurt learned from restor3d's limited market release (40:03) - How Kurt raised is last$100M+ round, and why fundraising is really a networking game (45:13) - What makes a great board, and how the wrong one can quietly derail a company

Medicaid reimbursements are shrinking, providers are pulling back, and vulnerable populations are losing access to care. Akido Labs is betting that AI can expand care capacity fast enough to reverse that trend.This week, Halle sits down with Prashant Samant, co-founder and CEO of Akido Labs, to discuss what it actually takes to scale care with AI. They explore why Akido built a full-stack healthcare company, how its AI operates inside real clinical workflows, and why the hardest patients are the best place to test whether this model works.We cover:Why he chose to build a full-stack care modelHow AI changes who can deliver care, and whereWhy most healthcare AI tools fail once they hit real clinical workflowsWhy the doctor shortage cannot be solved by training more doctorsHow the bottleneck in healthcare AI is absorption, not innovationAbout our guest:Prashant S. Samant is CEO and co-founder of Akido, a healthcare technology company that builds clinical AI and operates a multi-state medical network serving hundreds of thousands of patients. He co-founded Akido in 2015 through USC's Digital Health Lab. In 2023, he and his co-founders received the EY Entrepreneur of the Year–Greater Los Angeles Award. Samant is also a co-founder and board member of Grid110, a nonprofit accelerator supporting early-stage entrepreneurs. He holds a bachelor's degree in economics from Washington University in St. Louis.— Show Notes:Akido's recently-published white paper on street medicine—

How Sales Leaders Cracked the ABM Code On this episode instead of talking to marketers about account-based marketing, host Adam Turinas sat down with two sales leaders who have built and executed ABM programs from the ground up. They bring sharp, practical views on what it actually takes to make ABM work. His guests are Clint Mooneyham, VP of Sales at Sagility, a healthcare operations company serving payers and providers, and Tony Mancuso, an enterprise sales leader on the growth team at Onymos, a Series A AI startup focused on diagnostic labs and precision medicine. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Tandem Health CEO Lukas Sarri discusses Tandem's proposition and its plans across Europe

In this episode of the BRAVE Southeast Asia Tech Podcast, Jeremy Au sits down with Jay Fajardo, serial entrepreneur and CEO of BetterClinic, straight from Manila, Philippines. Jay discusses his return to the founder's seat at age 58, driven by the massive paradigm shift of the Artificial Intelligence supercycle. We dive deep into how AI is completely transforming digital healthcare by eliminating doctor burnout and drastically reducing administrative "pajama time" from 40% to 10%. Jay also reveals why AI makes being a solo founder an absolute superpower, how cloud tools are changing the venture capital landscape, and the looming impact of AI on the Philippine BPO industry. If you are building a startup in Southeast Asia or are fascinated by the future of AI health tech, this is a masterclass in adapting to technological shifts. 00:00 - Introduction & The AI Supercycle 01:55 - The Shift from Ecosystem Builder to AI Founder 04:26 - Why AI is a "Superpower" for Experienced Founders 05:10 - Fixing Healthcare & Reducing Doctor Burnout 08:44 - Eradicating "Pajama Time": AI Scribes & Clinic Workflows 10:52 - A Hybrid Go-To-Market Strategy for HealthTech in SEA 14:43 - The Rise of the Solo Founder Movement 18:29 - Age vs. Experience: Building Startups in Your 50s 20:00 - The Future of AI in Medicine (An AI Assistant?) 22:50 - AI's Looming Threat to the Philippine BPO Industry 23:40 - 3 Key Takeaways Watch, listen or read the full insight at https://www.bravesea.com/blog/jay-fajardo-betterclinic Get transcripts, startup resources & community discussions at https://www.bravesea.com WhatsApp: https://whatsapp.com/channel/0029VakR55X6BIElUEvkN02e TikTok: https://www.tiktok.com/@jeremyau Instagram: https://www.instagram.com/jeremyauz Twitter X : https://x.com/jeremyau LinkedIn: https://www.linkedin.com/company/bravesea English: Spotify | YouTube | Apple Podcasts Bahasa Indonesia: Spotify | YouTube | Apple Podcasts Chinese: Spotify | YouTube | Apple Podcasts

Rachel Stauffer and Lisa Mazur join Julia Grabo to discuss key takeaways from the 2026 Health Tech Investment Forum and what they are watching for next in the health tech space.

This week on Pulse: Hot Topics, Louise and George dive into the major developments shaping the future of healthcare. Tech giants Google and OpenAI release purpose-built clinician AI tools; a landmark Science paper and commentary on the clinical reasoning capabilities of AI; Eric Topol calls out the paradox at the heart of medical AI; and OpenEvidence, the most-used clinical AI platform in the US walks out of Europe.Resources:Brodeur et al. Science paper LinkHopkins & Cornelisse commentary, Science LinkEric Topol, The Paradox of Medical AI Implementation LinkDigital Health Workforce Census (opens 1 May, ANZ) LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

The 2026 Point-in-Time Count found a slight decline in homelessness in San Diego County, including an 11% drop in street homelessness. But the number of homeless seniors is growing.On Midday Edition Wednesday, we talk with two leaders of local nonprofits addressing homelessness about what's working and the challenges that lie ahead.Then, we sit down with representatives from a local group spreading awareness about mental health needs within San Diego's Vietnamese community.Plus, a new book from TED Radio Hour's Manoush Zomorodi looks into how our modern tech-filled lives is changing our bodies — and what we can do about it.Guests:Melinda Forstey, CEO, Serving SeniorsGreg Anglea, CEO, Interfaith ServicesTri Nguyen, licensed marriage and family therapist, counseling faculty at San Diego State University Tri Luu, board director and chair of partnerships, Vietnamese American Youth AllianceManoush Zomorodi, host, author, "Body Electric: The Hidden Health Costs of the Digital Age and New Science to Reclaim Your Wellbeing"Resources:Vietnamese American Youth Alliance Mental Health ResourcesInternational Vietnamese Mental Health AssociationSan Diego Access & Crisis Line - Call or text 9-8-8 OR (888) 724-7240Yellow Chair Collective

Episode 76 - Rachel Murphy, founder of The Grafter, is a trusted UK operator known for building real business value. She has grown, scaled and sold multiple companies, including her second, Difrent, in a major eight-figure deal.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

AI is everywhere in healthcare, and May's big question is whether it's actually delivering. The money is flowing, the promises are bold, but some cracks are starting to show.Steve and Michael break down the month's biggest stories.We cover:Digital health hitting its strongest funding quarter since the pandemic peak, and why deal concentration tells the real storyHow Medvi built a billion-dollar GLP-1 company on fake doctor profiles, fake reviews, and a drug with zero bioavailabilityWhy AI in prior authorization and billing may be inflating healthcare costs rather than cutting themThe peptide craze: what the science says, what regulators have banned, and why Michael is actually taking oneHow AI could collapse today's narrow medical specialties into a "generalist specialist" modelNew research showing Epic's out-of-the-box AI models fall short on real-world clinical benchmarks—Show notes:Rock Health Q1 2026 Funding ReportNYT Profile of Medvi + Futurism InvestigationPeterson Health Technology Institute: Administrative AI ReportSTAT News / Undark: BPC-157 and the Peptide CrazeHealth Affairs Scholar: Kocher & Wachter on the Generalist-Specialist ModelSpringer Nature / Journal of General Internal Medicine: Epic AI Model Meta-Analysis—

Recorded 3/3/26Vincent's Slava Rubin and Sacra's Jan-Erik Asplund take an in-depth look at the Healthtech sector, and key startups Oura, Abridge, and Open Evidence, as well as OpenAI's impact on the industry.

In this episode of Medsider Radio, we sat down with Alfred Griffin, co-founder and CEO of LightForce.LightForce is the developer of the world's first fully customized 3D-printed bracket system directly personalized for each patient's digital treatment plan.Alfred holds a DMD and PhD in Craniofacial Biology from the Medical University of South Carolina and completed his orthodontic residency at Harvard School of Dental Medicine, where he currently serves as faculty and the Board of Fellows. An ABO-certified practicing orthodontist, he continues to see patients every month while running the company.In this interview, Alfred shares how applying existing technology to an overlooked market can unlock a larger opportunity, how adoption friction is a design problem, and why scaling a new category requires treating operations as a core product investment.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Alfred Griffin.KEY MOMENTS FROM THE INTERVIEW(02:43) - How growing up in a family of dentists shaped Alfred's path into orthodontics (07:41) - How LightForce uses digital planning and 3D printing to create fully customized braces (08:48) - Why LightForce isn't a brilliant idea, but an obvious fix for the teen braces market that aligners missed (12:19) - How LightForce is like Google Maps for teeth, eliminating detours and removing inefficiencies (17:30) - How Alfred built LightForce around his clinical strengths and hired for experience to round out the gaps (30:56) - The 3-part secret to LightForce adoption by physicians (36:42) - How Alfred approaches fundraising, matching investors to the company's stage and needs (41:51) - About LightForce's digital factories and why they're the company's core moat

Over the last six months, Health Launchpad has seen inbound meetings grow by 89% year over year, direct and referral traffic increase by 3.6x, and session engagement run 35% longer from AI-sourced visitors. Perhaps most telling, prospects are regularly showing up to first calls already familiar with who they are and what they do, because they were found through ChatGPT or Claude, not through Google or any outbound campaign. On this episode, host Adam Turinas sits down with Mark Erwich, our Chief Strategy Officer, to walk through exactly how we got here and what you can do to see similar results. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. In this episode Louise and George sit down with Dr Mehmood Khan, CEO of Hevolution Foundation, and Her Royal Highness Princess Dr Haya Bint Khaled Bin Bandar Al Saud, Senior Vice President of Research at Hevolution. Based in Riyadh and backed by Saudi Arabia's Vision 2030, Hevolution is the world's largest philanthropic funder of healthspan science, with over USD $400 million allocated in just three years.Timed with the release of the second edition of Hevolution's Global Healthspan Report - the most comprehensive look at the field across 23 countries - this conversation moves beyond the longevity hype to explore what it takes to extend healthy human life for the benefit of all.In this episode:Healthspan, not longevity - Why Hevolution is focused on keeping people physically, mentally, and financially independent, and why a global non-profit is the right vehicle for a challenge governments and private enterprise can't tackle alone.Why Saudi Arabia, why now - Princess Dr Haya on the demographic shift driving the kingdom's leadership, and why a young population on the brink of ageing is uniquely placed to redesign systems before they break.The science that has scientists excited - GLP-1 agonists, senotherapeutics, CRISPR, and cellular reprogramming, and why the real breakthrough is the convergence of these fields, not any one of them in isolation.A jaw-dropping case study - Dr Khan walks through how rejuvenating aged liver cells eliminated chronic Hepatitis B in animal models, with first-in-human trials now underway. A profound example of aging biology rewriting the rules for treating incurable diseases.What clinicians need to know - Two-thirds of healthcare professionals are now getting monthly healthspan questions from patients. Princess Dr Haya on the shift from reactive to proactive care, and the urgent need for evidence-based healthspan protocols.A message for policymakers - Why the Minister of Finance, not just the Minister of Health, needs to be at the table, and why retirement, education, and workforce policies built for a 1%-over-65 world are catastrophically out of date.Where digital health innovators should be looking - The five years that could be cut from drug development with better data tools, the four proven interventions that lend themselves to digital monitoring, and why we already have the technology - just not the policy frameworks to deploy it.Connect with Hevolution on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+IT

Forty million people use ChatGPT for health-related questions every day, making it one of the most widely used tools for health information in the world. So what is their team doing to maximize impact and minimize harm? For one, they've brought in hundreds of physicians globally to continuously review outputs and shape how the models respond across different scenarios, literacy levels, and edge cases. Second, they've hired my Rock Health co-founder, Nate Gross, MD, as their VP of Health.In this full-circle episode, I sit down with Nate, who also co-founded Doximity (DOCS) and knows a thing or two about building in digital health. We discuss the astonishing speed of AI progress, how models are trained for safety and accuracy, and what this technological evolution means for every part of the healthcare system.Key topics:How ChatGPT is becoming a 24/7 front door for health questions, and whether it is replacing Dr. Google or starting to compete with the healthcare system itselfHow OpenAI is trying to reduce hallucinations, avoid sycophantic behavior, and build guardrails for sensitive use cases like mental healthOpenAI's goals to “raise the floor, sweep the floor, and raise the ceiling” with new product launches like ChatGPT for Clinicians and GPT-RosalindHow Nate thinks about the AI race and what winning in healthcare actually requiresWhere startups should focus their efforts now that specialized products are launching for clinicians and life sciencesThe single hardest problem in healthcare that AI, according to Nate, probably won't fix anytime soon— About our guest:Dr. Nate Gross is the VP of Health at OpenAI. He previously co-founded Doximity and Rock Health. He graduated from the Emory University School of Medicine with an MD, Harvard Business School with an MBA, and Claremont McKenna College with a BA in Government. He serves as affiliated faculty for the Clinical Informatics Fellowship at Stanford.— Show notes:ChatGPT for CliniciansChatGPT for Health (for patients)OpenAI for HealthcareGPT-Rosalind—

How Intimate Events Drive Deeper Pipeline On this episode host Adam Turinas sits down with two guests who are doing something genuinely different in the world of healthcare events, and they represent two very different moments in the buyer journey. First, Jane Bogue, SVP and Chief Growth Officer at CHIME, gives a refreshingly honest take on how to get real value from a CHIME membership so that tomorrow's HIT buyers view you as partners. She also covers the mistakes that will guarantee you waste your investment. Then he talks with Jeremy Gottlich, Partnerships Lead at Elion Health. Elion is a research and intelligence platform focused on AI and emerging healthcare technology. They run intimate summits built around one very specific design principle: confirmed buying intent. Only health system leaders who are actively evaluating solutions in a specific category get invited, and vendor attendance is capped tightly. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Can knowing your death date help you live longer? Explore the Death Clock app, AI longevity predictions, and how small lifestyle shifts can extend your life. https://bit.ly/4cBBrDKA study of 60,000 people found that just a few minutes of better sleep, a little more movement, and small changes in diet could add years to your life. Not dramatic changes, small ones.Now imagine an app that tracks those choices—and tells you, in real time, how they're affecting the day you're likely to die. I tried it. It gave me a date. And then, after one good night of sleep, it gave me a different one. Today, we're exploring what happens when technology meets mortality—and whether knowing your “death date” changes how you live. Because Everyone Dies. And every day is a gift.In this Episode:00:00 - Predicting Mortality: Would You Want to Know Your Death Date?03:17 - Ikaria Longevity Recipe: Zucchini-Herb Pie04:02 - The Voice of Pink Floyd: Clare Torry's "Great Gig in the Sky"09:09 – An App Called Death Clock: Learn How AI Calculates Life Expectancy11:17 - Preventive Health Protocols: Turning Data into Longevity15:21- Can One Night of Sleep Shift Your Death Date? Learn How a 60,000-Person Study Backs Small Changes in Lifespan17:33 - Facing the Countdown: Listener Perspectives on Mortality23:50 - Active Devotion: Lyrics from "The Great Gig in the Sky"25:10: OutroSupport the showConnect with Us: Email our Host: mail@every1dies.org  Website: https://every1dies.org: Find show notes, links and expanded resources Follow Us: Facebook | Instagram | YouTube  

HIMSS '26: CMS Health Tech Ecosystem Updates from Ryan Howells Live from the Healthcare Now Radio studio at HIMSS, Jared speaks with Ryan Howells, Principal at Leavitt Partners. Ryan recaps a series of recent announcement from CMS about their Health Tech Ecosystem, what's coming next, and why it's significant for anyone paying attention to the consumer experience space.  All that, plus our newest shout out to consumer and retail brands working in healthcare.  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Nearly one billion prescriptions are abandoned at the pharmacy counter every year, often because patients are blindsided by the cost.This week, co-host Halle Tecco is joined by Wendy Barnes, President and CEO of GoodRx, to discuss the chaos of prescription drug pricing, the murky world of Pharmacy Benefit Managers (PBMs), and how digital tools are changing patient affordability. They break down the layered system of manufacturers, payers, and pharmacies that creates inconsistent pricing, and explore the current push for greater transparency.We cover:The cascade of drug pricing: from initial manufacturer costs and rebates to payer and pharmacy contracts, which results in vast price variability for consumersWhat it would take to get to price transparency in drug pricingThe current pressures on PBMs, including efforts to ban "spread" and the practice of offshoring rebate contracting for tax advantagesWhy pharmacies haven't gone online like other areas of consumer goodsThe future of medication access, including the growth of pharma's direct-to-patient programs and the low current adoption of home delivery despite widespread retail pharmacy closures— About our guest:Wendy Barnes is the President and CEO of GoodRx. She has over 30 years of leadership experience across the pharmacy and medical benefit industry. Most recently, Wendy served as CEO of RxBenefits, where she led the company in providing pharmacy benefit support to more than 2,000 self-insured clients, representing over 3 million lives. Prior to that, she served as President of Express Scripts Pharmacy, overseeing operations for 100 million beneficiaries. Her leadership spans roles at Rite Aid, Premier Inc., and the U.S. Air Force, where she served as a Medical Service Corps Officer. She holds a B.S. degree in Biochemistry from the United States Air Force Academy and an M.B.A. degree from the University of Alaska Anchorage.—

In this episode of Run the Numbers, CJ sits down with Manu Diwakar, CFO of Virta Health, to unpack why health tech breaks traditional SaaS thinking. They get into the realities of running a business where outcomes matter, half the company are medical professionals, and efficiency can't come at the expense of care. It's a conversation about sustainable scaling, smarter reinvestment, and building for durability over hype.—SPONSORS: SpendHound is a SaaS spend management platform built for finance and procurement teams that want visibility and leverage in every deal. By tracking all your software, benchmarking pricing across thousands of vendors, and surfacing contracts and renewals, SpendHound helps you stop overpaying and negotiate with confidence. Trusted by teams at ZoomInfo and Hootsuite. Get started at https://www.spendhound.com/cjBrex is an intelligent finance platform that combines corporate cards, built-in expense management, and AI agents to eliminate manual finance work. By automating expense reviews and reconciliations, Brex gives CFOs more time for the high-impact work that drives growth. Join 35,000+ companies like Anthropic, Coinbase, and DoorDash at https://www.brex.com/metricsAleph is a modern FP&A platform built for teams that want more than another planning tool. By connecting your ERP, CRM, and other systems into one trusted data layer with AI workflows, Aleph helps you move faster with real-time insights. Get a personalized demo at https://www.getaleph.com/runRightRev is an automated revenue recognition platform built for teams that have outgrown spreadsheets and billing tool workarounds. It handles high-volume subscriptions, usage-based contracts, and mid-cycle upgrades, so you can scale without scrambling at month-end. For RevRec that keeps your books clean, visit https://www.rightrev.com/CJRillet is an AI-native ERP built for modern finance teams that want to close faster without fighting legacy systems. Designed to support complex revenue recognition, multi-entity operations, and real-time reporting, Rillet helps teams achieve a true zero-day close—with some customers closing in hours, not days. If you're scaling on an ERP that wasn't built in the 90s, book a demo at https://www.rillet.com/cjEY works with high-growth tech companies to navigate the messy realities of scaling—from regulatory requirements to IPO readiness. By helping teams get it right early and often, EY lets founders stay focused on building while reducing risk as they grow. Learn more at https://www.ey.com/techstartups—LINKS: Mostly Talent: https://mostlymetrics.typeform.com/to/cLTxtAsNGuest: https://www.linkedin.com/in/manu-diwakar-1aa578/Company: https://www.virtahealth.com/CJ: https://www.linkedin.com/in/cj-gustafson-13140948/Mostly metrics: https://www.mostlymetrics.com—TIMESTAMPS:0:00 Preview and intro1:18 Welcome and guest intro3:02 What sector is health tech?4:34 Virta go to market explained7:01 B2B to B2C model9:00 Value based care and ROI guarantees9:18 Half the company are medical professionals10:36 Sponsors — SpendHound | Brex | Aleph14:03 Annual planning process16:42 Shape of the curve17:33 TAM: metabolic health is massive20:45 Fee for service vs. value based care24:16 Sponsors — RightRev | Rillet | EY27:24 Unique costs of health tech: billing, compliance30:54 Corporate practice of medicine31:44 North star: members under management32:43 The flywheel: $250 charge, $500 saved33:28 Early stage CFO job is easy35:28 Bad habits baked in during high growth38:02 Choosing not to profit vs. not turning a profit41:15 Running a VC-backed business for sustainability42:07 People, tech and process framework44:31 Hiring philosophy: hard work, learning, curiosity48:26 Athletes vs. experts in hiring50:03 Clock hands interview question50:49 Lightning round51:09 Screwed up: having hard conversations late51:57 Advice to younger self52:15 Finance software stack52:42 Craziest expense story53:47 Credits

What Actually Makes Event Marketing Work in Healthtech Big events like HIMSS and VIVE are the biggest single investment for many health tech marketing companies. They serve many needs, but there is always an expectation of a positive ROI from them. On this episode host Adam Turinas goes deep with two highly experienced and brilliant health tech marketers on their strategies for creating highly engaging events that deliver strong results: Lea Chatham, VP of Marketing at Heidi Health, and Aaron Bours, CMO at Hyro.

Send us Fan MailAre you being too hard on yourself? The problem you've been trying to fix might need something other than the discipline.In this episode of Female Founder Unplugged, Lindsay sits down with Aja Beckett — app developer, GLP-1 user, and accidental CEO — who built her app Shotsy from a nights-and-weekends side project into the #1 GLP-1 tracking app in the Health & Fitness category. "Her story is as much about reclaiming her health as it is about building a business from scratch."✨ Episode Highlights

Send us Fan MailWhy does it take five years to diagnose a child with a genetic disease when the answer is available in 48 hours?In this clip from our episode “How Genomics Is Transforming Rare Disease Care”, host John Driscoll and guest Katherine Stueland, CEO of GeneDx, expose one of the most frustrating gaps in pediatric medicine today.

Pete McCanna, CEO of Baylor Scott & White Health, believes that health systems are built around the wrong objective… and he has an ambitious goal to change that.This week, Halle sits down with McCanna to unpack how one of the largest and most successful health systems in the country is shifting from a supply-driven model to one built entirely around the customer. They discuss why legacy systems operate like “walled castles,” what it takes to redesign care around real conditions instead of departments, and how Baylor Scott & White is testing a model that prioritizes access, personalization, and long-term trust over short-term profit.We cover:Why most health systems are structured to fill capacity, not create value for patientsThe reason why he uses the term "customer" instead of "patient" (and how his colleagues initially responded)How loyalty and trust make it economically sound to offer services that lose money.The strategy for deploying AI to create product differentiation for patients rather than just improving internal efficiencyThe limits of the “payvider” model and why it's harder than it looksThe three healthcare laws he thinks need to be rewritten—About our guest: As CEO of Baylor Scott & White Health, Peter (Pete) McCanna is focused on empowering customers to live well by reimagining traditional healthcare—offering more convenient, personalized, and informed experiences. He is leading Baylor Scott & White's customer-centric transformation by bringing together the system's 59,000 team members around a common goal to keep people healthy and feeling connected and supported.Before becoming CEO, Pete served as the health system's president. In that role, he drove operational excellence, strengthened clinical alignment, scaled the system's digital health platform, MyBSWHealth, and deepened academic partnerships to address the critical need for healthcare professionals.Pete has nearly 40 years of industry experience. As executive vice president and chief operating officer at Northwestern Medicine, he exceeded targets for operating revenue, quality, patient experience, and employee engagement, making it one of the top 10 academic health centers in the country.Known as a thoughtful and innovative leader, Pete formerly served as chief financial officer at New Mexico-based Presbyterian Healthcare Services and the University of Colorado Hospital.Passionate about transforming healthcare, Pete was named one of Modern Healthcare's “100 Most Influential People in Healthcare.” Driven by a deep sense of purpose, Pete currently serves as the inaugural board chair of Longitude Health, an innovative healthcare collaborative, and as a board member of University of Michigan Health, Texas Hospital Association, and Catholic Extension. He holds a master's degree in Public Affairs at the University of Texas at Austin and a bachelor's degree in English from the University of Michigan.Baylor Scott & White Health is the largest not-for-profit health system in the state of Texas. It includes 55 hospitals, more than 1,300 access points, a health plan, a research institute, and an accountable care organization, plus Levanto—a company offering digitally-enabled health solutions—and 3.5 million customers connected through MyBSWHealth.—Snow notes: Visit BSWHealth.com to learn more.Download the MyBSWHealth app.Explore Levanto.Health to learn about employer solutions built on Baylor Scott & White's digital platform and care model.—

The Thought Leadership Gap in Healthtech A lot of healthtech thought leadership is interchangeable. Swap out the logo, change the company name, and much of the time, nobody would notice. On this episode host Adam Turinas and guest Adrianna Hosford discuss what great thought leadership looks like and how it happens. Adrianna Hosford is the Chief Communications Officer and Head of Marketing at Artera, the AI patient communication platform that just won Best in Class. She came up through corporate reputation at Ketchum, one of the world's premier PR firms, which means she brings a reputational lens to everything, and that changes how you see the problem. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Discover how WHOOP is building an AI-powered health data infrastructure that is redefining how we understand human health. Emily Capodilupo, Senior Vice President of Research, Algorithms, and Data at WHOOP, explains how continuous physiological data is uncovering new opportunities in predictive health through AI, from presymptomatic disease detection to biological age scoring. She examines the governance challenges of deploying AI in a regulated environment and what it takes to build the data trust required to make it work at scale. Key Moments: How WHOOP Built Its AI and Data Foundation (00:57): Emily explains how WHOOP's early focus on elite athlete performance shaped the data collection rigor and multidisciplinary science organization that now powers its predictive health capabilities. She outlines the model she built across AI, machine learning, clinical research, and digital signal processing, and why starting with the highest-demand use case created a data foundation built to scale. The Power of Continuous Data (06:21): Emily draws on WHOOP's sleep research to show how continuous physiological data reveals patterns that would be invisible without longitudinal tracking. She shares findings linking sleep architecture to metabolic disease, cancer risk, and cognitive decline, illustrating why the depth and continuity of a data set determine what insights are actually possible. The Data Governance Challenge of Acting on Sensitive Data (13:17): Emily shares how WHOOP's respiratory rate data could detect COVID infection up to three days before symptom onset in over 80% of cases, but a denied FDA application left the company holding actionable insights it was legally prohibited from sharing. She examines the governance tension that emerges when your data capabilities move faster than the regulatory frameworks designed to govern them. Turning Complex Multi-Signal Data Into a Single Actionable Metric (27:32): Emily introduces WHOOP's Healthspan feature, which translates physiological and behavioral data across nine components into a single biological age score tied to all-cause mortality risk. She explains why distilling complex data into one number is more motivating than presenting raw risk statistics, pointing to research that shows how age-based framing drives stronger behavior change. Building Data Trust and Privacy Infrastructure at Scale (31:40): As WHOOP moves into FDA-cleared products and more sensitive data collection, Emily outlines the governance principles that underpin member trust. She argues that for any organization building on sensitive personal data, the asymmetry between earning trust and losing it should be a foundational design constraint. Key Quotes: "It takes 13 years to earn the trust and one mistake to lose it. And that kind of asymmetry is constantly top of mind." - Emily Capodilupo "We were able to show that we could detect COVID up to three days before symptom onset in over 80% of cases." - Emily Capodilupo “ WHOOP has been collecting data [for] over 12 years. We're working on a lot of new types of algorithms that are able to help people understand their bodies in ways that we might not have appreciated…even just a couple years ago.” - Emily Capodilupo "One of the ways that AI has advanced the product... is this ability to chat with WHOOP in natural language, the way you might chat to a doctor or a trainer or a coach." - Emily Capodilupo Mentions Harvard Study | Analyzing changes in respiratory rate to predict the risk of COVID-19 infection  Cornell Study Uses WHOOP Sleep Data to Monitor Patients at Risk for Alzheimer's Can Data Help Us Sleep Better? | WHOOP There's More to Sleep than Sleep Need: The Importance of Sleep Consistency | WHOOP Cribsheet & Expecting Better 2 Books Collection Set By Emily Oster  The Family Firm: A Data-Driven Guide to Better Decision Making in the Early School Years By Emily Oster  Guest Bio  Emily Capodilupo is an award-winning AI and research leader with more than 13 years of experience building and scaling science-driven organizations in fast-paced startup environments. She began her career as an emergency medical technician before studying neurobiology and human sleep at Harvard University and conducting research at Brigham and Women's Hospital. Emily is driven by a passion for using data to solve hard problems and advance our understanding of human physiology. Along the way, she "accidentally" became a data scientist, recognizing that the biggest breakthroughs in health require not just rigorous science, but big data and bold technology.  As WHOOP's first employee, Emily founded and now leads the company's science organization, pioneering a new model of health that begins long before diagnosable illness and is continuous, personalized, AI-powered, and designed to empower individuals to take the driver's seat in their own well-being. She has built and scaled multidisciplinary teams across artificial intelligence, machine learning, digital signal processing, clinical research, and engineering to translate real-time physiological data into actionable insights that improve performance, resilience, and long-term health. Emily's work sits at the intersection of wearable technology, digital biomarkers, and predictive health, helping shift healthcare from reactive treatment to proactive optimization. Hear more from Cindi Howson here. Sponsored by ThoughtSpot.

What if your startup isn't failing because of the idea… but because no one is truly communicating clearly enough on the product development and build? Joel is the founder and CEO of Brewer Digital, and today we explore what really makes or breaks a startup in today's fast-moving, tech-driven world. Joel shares why most startups don't fail due to bad ideas, but because of breakdowns in communication across founders, developers, and customers. We talk about how entrepreneurs can avoid wasting time and money, the role of AI in product development, and why having the right partner early on can be the difference between momentum and missed opportunity. Joel also opens up about hard leadership lessons, navigating business cycles, and what it takes to build something scalable with clarity and confidence. Here are the highlights: ● Startups Fail from Miscommunication, Not Bad Ideas: Most startups struggle because teams and customers aren't aligned on what should actually be built. ● Clarity Removes Barriers to Growth: Clear pricing, deliverables, and direction help founders move faster and make confident decisions. ● AI Is a Tool, Not a Strategy: Founders should focus on solving real problems first instead of forcing AI into their product. ● Time and Money Are Easily Wasted Without Guidance: Going it alone often leads to costly mistakes that the right partner can help avoid. ●     Resilient Leadership Comes from Real Challenges: Navigating downturns reinforced the need for strong sales systems and adaptability.   About the guest: Joel Brewer is the Founder and CEO of Brewer Digital, a US based software development agency that helps early stage startup founders launch products with confidence. A software developer himself, Joel works directly with founders who have an idea, some traction, or fresh funding but no internal engineering leadership. His team builds MVPs, rescues failed offshore projects, and helps founders make smart technical decisions before they burn runway. Joel believes most startups do not fail because of bad ideas. They fail because they build the wrong thing or build it the wrong way. Brewer Digital partners with founders who value communication, clarity, and long term thinking over cheap shortcuts. With deep experience in HealthTech and FinTech, Joel helps founders decide what to build next, why it matters, and how to launch without creating technical debt that slows them down later.   Connect with Joel: Website: https://www.brewerdigital.com/ LinkedIn: https://www.linkedin.com/in/joel-brewer-69680037/   Connect with Allison: Feedspot has named Disruptive CEO Nation as one of the Top 25 CEO Podcasts on the web. LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/ Website: https://www.disruptiveceonation.com/    #CEO #leadership #startup #founder #business #businesspodcast  Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 75 - HealthTech Hour comes live from Digital Health Rewired at the NEC. Steve is joined by Alex Lawrence (Health Foundation Fellow), Hassan Chaudhury (digital health advisor) and Hayley Grafton, a digital nurse leader.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

We're back with our monthly rundown of the top headlines in health tech!Today, Halle flies solo to share the biggest stories that shaped Q1, from the rising pressures on PBMs to how consumers are using AI.Stories covered:What's happening to PBMs (it's not pretty)New data from Rock Health on consumer use of AISocial media companies find liable for addictive designHealthcare hiring is slowing as efficiency becomes the focusHave we finally bent the healthcare cost curve in the United States?—The Heart of Healthcare podcast was nominated for a Webby award! We'd so appreciate if you could create a quick account and vote for us here. —

Last year, his independent pharmacy spent $13 million on brand-name drugs for patients processed by the three biggest Pharmacy Benefit Managers (PBMs) which earned a profit margin of 0.01%.In this episode, Halle speaks with Alec Ginsberg, owner and fourth-generation pharmacist at C.O. Bigelow, the oldest surviving apothecary–pharmacy in the United States. Alec is fighting against the forces squeezing independent pharmacies and charting a course for the future of the pharmacist.We cover:How the roll-up of PBMs, health plans, and retail pharmacies changed everythingWhat led him to remove his pharmacy's Rx-filling robotThe dramatic decline of independent pharmacies along with the closures of big box pharmacy storesThe one health policy he would put in place today to save independent pharmaciesThe history of the pharmacist's role and what's nextWhat he really thinks about compounding pharmacies and the Hims vs. Novo lawsuit—About our guest: Alec Wade Ginsberg is the fourth-generation pharmacist, owner, and Chief Operating Officer of C.O. Bigelow Apothecary, America's oldest pharmacy, founded in 1838 and still operating in New York City's West Village. With a Doctor of Pharmacy degree from the University of North Carolina Eshelman School of Pharmacy, Alec bridges the clinical world of pharmacy with the realities of modern consumer culture.At Bigelow, he oversees the brick-and-mortar beauty retail and pharmacy operations, navigating everything from prescription drug shortages to the pressures of today's PBM-dominated marketplace. Beyond the counter, Alec is the founder and writer of Drugstore Cowboy, a weekly newsletter that dissects the intersection of drugs, business, and consumer culture — making the hidden mechanics of the U.S. healthcare system both understandable and entertaining for thousands of readers.His work has been featured across national media, and he's become a trusted voice for translating complex pharmaceutical issues — from GLP-1s to compounding to drug pricing — into plain English. Alec's mission is simple: to make Americans smarter about the pills in their cabinets and the system that puts them there.—Show notes:Drugstore Cowboy - Alec's free and super interesting newsletterC.O. Bigelow - The Nation's Oldest ApothecaryVirtual GLP-1 startups: Pill mills or the future of obesity care?—